Hi NZT
About 33c seems far too low- that would mean a MC of only ~$150M for a company with a positive phase 3 trial outcome (but not Final decision from FDA et al) with only a year before the final decision
I was thinking at least 80c at that point (giving a MC of just $360M)
if it gets approval in a years time, the MC will be over $2B (or over >$4 p.s.)- all IMHO .
Ann: Application for quotation of securities - DXB, page-33
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.015(3.41%) |
Mkt cap ! $250.5M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 46.0¢ | 43.5¢ | $698.9K | 1.543M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 136150 | 45.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 27000 | 2 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| DXB (ASX) Chart |